About: Noxopharm Limited, a clinical-stage biotechnology company, engages in the development of therapies for chronic inflammation, autoimmune diseases, and cancer in the Pan-Pacific region. The company develops Sofra, a platform designed to regulate innate immune signaling with greater precision; and Chroma, a small molecule technology platform focused on the development of multiple drug candidates for cancer treatment. It is also developing SOF-SKN, a topical therapy that has completed Phase I clinical trial for cutaneous lupus erythematosus; and CRO-67, a dual-cell preclinical drug candidate for the treatment of pancreatic cancer. In addition, the company intends to improve mRNA vaccines. Noxopharm Limited was incorporated in 2015 and is based in Glenhaven, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.05 (-10.91%)
NOX ASX Noxopharm Ltd
Noxopharm Ltd share price
Atividade de preço de NOX
Último preço
$ 0,050
Variação (24h)
-0,01 AUD (10,91%)
Volume
5.54K
Volume (média 4 sem.)
-
Abertura
$ 0,05
Variação do dia
$ 0,05 - $ 0,05
Fechamento anterior
$ 0,06
Último negócio
26 Oct, 1:43 am GMT+0
Atrasado
26 Oct, 1:43 am GMT+0
NOX price performance
Atrasado
26 Oct, 1:43 am GMT+0
quote.marketSignals